Eli Lilly attempts to block Sun Pharma's generic Strattera

09/25/2007 | Business Standard (India)

Eli Lilly & Co. has filed a patent infringement suit against Sun Pharmaceutical Industries, which seeks to produce and sell a generic version of Lilly's attention deficit hyperactivity disorder drug Strattera. In a complaint filed Sept. 20, Eli Lilly said the company would be "irreparably harmed" by the FDA's approval of Sun's request.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY